机构：[1]Department of Haematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.[2]State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.[3]Department of Haematology, Peking University First Hospital, Beijing, China.[4]Department of Haematology, Second Xiang-ya Hospital, Central South University, Changsha, China.[5]Department of Haematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.[6]Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.[7]Department of Haematology, Sheng Jing Hospital of China Medical University, Shenyang, China.中国医科大学附属盛京医院中国医科大学盛京医院[8]Department of Haematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.[9]Department of Haematology, Shanxi Province Cancer Hospital, Taiyuan, China.[10]Department of Haematology, Guangdong Provincial People's Hospital/Guangdong Academy of Medical Sciences, Guangzhou, China.广东省人民医院[11]Bone Marrow Transplantation Center, The First Affiliated Hospital of Zhejiang Medical College, Zhejiang University, Hangzhou, China.浙江大学医学院附属第一医院[12]Department of Haematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.华中科技大学同济医学院附属同济医院[13]Department of Haematology, First Hospital of China Medical University, Shenyang, China.[14]Department of Haematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China.江苏省人民医院[15]Department of Haematology, West China Hospital Sichuan University, Chengdu, China.四川大学华西医院[16]Department of Haematology, China-Japan Friendship Hospital, Beijing, China.[17]Department of Haematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, China.吉林大学中日联谊医院[18]Department of Haematology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.[19]Department of Haematology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.[20]Department of Haematology, Xinqiao Hospital, Army Medical University, Chongqing, China.[21]Department of Haematology, Fujian Medical University Union Hospital, Fuzhou, China.[22]Department of Haematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.[23]Department of Haematology/Oncology, Chongqing University Cancer Hospital, Chongqing Cancer Hospital, Chongqing, China.[24]Department of Haematology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.[25]Department of Lymphoma & Haematology, Hunan Cancer Hospital/The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, China.[26]Institute of Haematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.华中科技大学同济医学院附属协和医院[27]Department of Haematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.[28]Department of Lymphoma and Myeloma, State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.[29]Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.[30]Department of Haematology, The First Affiliated Hospital of USTC, Hefei, China.[31]Department of Haematology, The Second Hospital of Dalian Medical University, Dalian, China.[32]Department of Haematology, The First Hospital of Jilin University, Changchun, China.[33]Department of Haematology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.[34]Department of Haematology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.[35]Department of Haematology, Second Hospital of Hebei Medical University, Shijiazhuang, China.[36]Department of Haematology, Tianjin Medical University General Hospital, Tianjin, China.[37]Department of Haematology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.[38]Department of Haematology, Huashan Hospital, Fudan University, Shanghai, China.[39]Department of Haematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.[40]Department of Haematology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.[41]Department of Haematology, Shanxi Bethune Hospital, Taiyuan, China.山西白求恩医院[42]Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
第一作者机构：[1]Department of Haematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.[2]State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
共同第一作者：
通讯作者：
通讯机构：[1]Department of Haematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.[2]State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.[*1]Department of Haematology and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China.
推荐引用方式(GB/T 7714)：
Zhang Lu,Dong Yu-Jun,Peng Hong-Ling,et al.A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria[J].The Lancet Regional Health. Western Pacific.2023,34:100720.doi:10.1016/j.lanwpc.2023.100720.
APA：
Zhang Lu,Dong Yu-Jun,Peng Hong-Ling,Li Hao,Zhang Ming-Zhi...&Li Jian.(2023).A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.The Lancet Regional Health. Western Pacific,34,
MLA：
Zhang Lu,et al."A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria".The Lancet Regional Health. Western Pacific 34.(2023):100720
